Nutritional status of children with familial hypercholesterolemia
https://doi.org/10.33667/2078-5631-2021-21-62-67
Abstract
Aim. To study the features of the nutritional status, including physical growth, body composition, energy value of the diet and the amount of cholesterol consumed with food, in children with familial hypercholesterolemia (FH).
Patients and methods. The study included 39 children (19 girls, 20 boys) with familial hypercholesterolemia, both genetically confirmed (n = 11) and established on the basis of Simon Broome criteria (n = 28), aged 9.9 [6.0; 12.9] years. All children were assessed for physical growth based on the Z-score BMI, Z-score height, Z-score body weight/height calculated using the programs Anthro and Anthro plus; analysis of actual nutrition using a standard application program; study of body composition using the InBody 770 bioimpedance analyzer, the basal metabolic rate measured by indirect calorimetry.
Results. 55 % of children with FH had harmonious physical growth, 27 % had a body weight deficit, 18 % were overweight or obese. 53 % of patients consumed more than 200 mg of cholesterol per day, while half of them consumed more than 300 mg of cholesterol per day. The range of excess consumption of cholesterol in comparison to the recommended physiological needs for patints with FH ranged from 24 to 67 %. The fat mass according to the body composition in 47 % of patients with FH is within the normal range, in 39 % it is reduced by 18-74 %, in 14 % it is increased by 14-197 %. The median fat percentage was 17.8 [12.7; 22.4]%. According to indirect calorimetry, it was found that the level of resting energy needs corresponded to age needs in 21 % patients, in 8 % it was decreased of 2-26 %, in 2/3 of children its increase was recorded by 3-69 %. The rate of fat oxidation, on the contrary, was increased in 71 % of children by 3-86 % and reduced only in 6 %.
Conclusion. The physical growth of children with FH was mainly average, harmonious, while a third of the children had a mass deficit. The level of the main indicators of lipid metabolism did not depend on the physical growth of patients. This pathology in children with normal body weight or with a body weight deficit often remains undiagnosed.
About the Authors
D. A. PoluninaRussian Federation
Diana A. Polunina - graduate student at Dept of Paediatric Gastroenterology, Hepatology and Diet Therapy, Federal Research Centre for Nutrition, Biotechnology and Food Safety; pediatrician, City Children's Polyclinic No. 39.
Moscow.
M. E. Bagaeva
Russian Federation
Madlena E. Bagaeva - PhD Med, senior research fellow at Dept of Paediatric Gastroenterology, Hepatology and Diet Therapy, Federal Research Centre for Nutrition, Biotechnology and Food Safety; assistant at Dept of Gastroenterology and Dietetics, Russian National Research Medical University n. a. N.I. Pirogov.
Moscow.
E. V. Pavlovskaya
Russian Federation
Elena V. Pavlovskaya - DM Sci, senior research fellow at Dept of Paediatric Gastroenterology, Hepatology and Diet Therapy.
Moscow.
T. V. Strokova
Russian Federation
Tatyana V. Strokova - DM Sci, professor, Dept of Paediatric Gastroenterology, Hepatology and Diet Therapy, Federal Research Centre for Nutrition, Biotechnology and Food Safety; head of Dept of Gastroenterology and Dietetics, Russian National Research Medical University n. a. N.I. Pirogov.
Moscow.
References
1. Russian recommendations for the diagnosis and treatment of familial hypercholesterolemia; Eurasian Journal of Cardiology, 2017 (2).
2. Clinical recommendations of the Ministry of Health of the Russian Federation. Familial hypercholesterolemia, Moscow, 2018.
3. Vaezi Z, Amini A. Familial Hypercholesterolemia. 2021 Jan 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan. PMID: 32310469.
4. Galimova L. F., Sadykova D. I., Slastnikova E. S., Usova N. E. Diagnosis of familial hypercholesterolemia in children: cascade screening from theory to practice. Cardiovascular Therapy and Prevention. 2020; 19 (3): 2348. (In Russ.) https://doi.org/10.15829/1728-8800-2020-2348
5. Narayanaswamy M., Sharma S. Polygenic Hypercholesterolemia. 2020 Dec 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan. PMID: 32644569.
6. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 1973; 52: 1544-68.
7. Beheshti SO, Madsen CM, Varbo A, Nordest-gaard BG. Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects. J Am Coll Cardiol. 2020 May 26; 75 (20): 2553-2566. DOI: 10.1016/j.jacc.2020.03.057. PMID: 32439005.
8. Mehta R, Martagon AJ, Galan Ramirez GA, Antonio-Villa NE, Vargas-Vazquez A, Elias-Lopez D et al. Mexican Familial Hypercholesterolemia Group. Familial hypercholesterolemia in Mexico: Initial insights from the national registry. J Clin Lipidol. 2021 Jan-Feb; 15 (1): 124-133. DOI: 10.1016/j.jacl.2020.12.001. Epub 2020 Dec 16. PMID: 33422452.
9. Sturm A. C., Knowles J. W., Gidding S. S., Ahmad Z. S., Ahmed C. D., Ballantyne C. M., Baum S. J., Bourbon M., Carrie A., Cuchel M., de Ferranti S. D., Defesche J. C., Freiberger T., Hershberger R. E., Hovingh G. K., Karayan L., Kastelein J. J.P., Kindt I., Lane S. R., Rader D. J. (2018). Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel. Journal of the American College of Cardiology, 72 (6), 662-680. https://doi.org/10.1016/j.jacc.2018.05.044
10. Diet for hypercholesterolemia in children. Questions of modern pediatrics. 2020; 19 (4): 309-315. DOI: 10.15690/vsp.v19i4.2140.
11. A modern strategy for the diagnosis and treatment of familial heterozygous hypercholesterolemia in children. Russian Bulletin of Perinatology and Pediatrics 2020; 65 (4): 27-40. DOI: 10.21508/1027-4065-2020-65-4-27-40.
12. Sadykova D. I., Galimova L. F., Slastnikova E. S. Diagnostic Characteristics of Familial Hypercholesterolemia in Children. Pediatric pharmacology. 2020; 17 (2): 124-128. (In Russ.) https://doi.org/10.15690/pf.v17i2.2098
13. Karapostolakis G, Vakaki M, Attilakos A, Marmarinos A, Papadaki M, Kou-manidou C, Alexopoulou E, Gourgiotis D, Garoufi A. The Effect of Long-Term Atorvastatin Therapy on Carotid Intima-Media Thickness of Children With Dyslipidemia. Angiology. 2021 Apr; 72 (4): 322-331. DOI: 10.1177/0003319720975635. Epub 2020 Nov 26. PMID: 33242982.
14. Kokoulina A. Yu. Dynamic assessment of the nutritional status of schoolchildren. Medicine: Theory and Practice, 2019; 4 (1): 219-222.
15. de Ferranti SD, Shrader P, Linton MF, Knowles JW, Hudgins LC, Benuck I, Kindt I, O'Brien EC, Peterson AL, Ahmad ZS, Clauss S, Duell PB, Shapiro MD, Wilemon K, Gidding SS, Neal W. Children with Heterozygous Familial Hypercholesterolemia in the United States: Data from the Cascade Screening for Awareness and Detection-FH Registry. J Pediatr. 2021 Feb; 229:70-77. DOI: 10.1016/j.jpeds.2020.09.042. Epub 2020 Sep 22. PMID: 32976895.
16. Malhotra A, Shafiq N, Arora A, Singh M, Kumar R, Malhotra S. Dietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemia. Cochrane Database of Systematic Reviews 2014, Issue 6. Art. No.: CD 001918. DOI: 10.1002/14651858.CD 001918.pub3
17. Gidding SS. Special Commentary: Is diet management helpful in familial hypercholesterolemia? Curr Opin Clin Nutr Metab Care. 2019 Mar; 22 (2): 135-140. DOI: 10.1097/MCO.0000000000000538. PMID: 30550385.
Review
For citations:
Polunina D.A., Bagaeva M.E., Pavlovskaya E.V., Strokova T.V. Nutritional status of children with familial hypercholesterolemia. Medical alphabet. 2021;(21):62-67. (In Russ.) https://doi.org/10.33667/2078-5631-2021-21-62-67